Real-world prospective data of small biopsy samples for tumor PD-L1 expression in non-small cell lung cancer

被引：0
|
作者：
Morikawa, K. [1 ]
Tsunoda, A. [1 ]
Inoue, T. [1 ]
Mineshita, M. [1 ]
机构：
[1] St Marianna Univ, Sch Med, Div Resp Dis, Kawasaki, Kanagawa, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1900P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Real-world evidenceand clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
    Song, Peng
    Zhang, Jingcheng
    Shang, Congcong
    Zhang, Li
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [32] Real-world utilization of PD-1/PD-L1 inhibitors with palliative radiotherapy in patients with metastatic non-small cell lung cancer
    Zhou, Zi-Chao
    Chen, Kai-Yan
    Li, Na
    Xie, Ming-Ying
    Sheng, Jia-Min
    Fan, Yun
    Huang, Zhi-Yu
    THORACIC CANCER, 2022, 13 (16) : 2291 - 2300
  • [33] EGFR Mutations and PD-L1 Expression in Early-Stage Non-Small Cell Lung Cancer: A Real-World Data From a Single Center in Brazil
    Pinto, Icaro Alves
    Cavagna, Rodrigo de Oliveira
    Virginio da Silva, Aline Larissa
    Dias, Josiane Mourao
    Santana, Iara Vidigal
    Souza, Laisa Caroline
    Ferreira da Silva, Flavio Augusto
    Biazotto Fernandes, Maria Fernanda
    Junqueira Pinto, Gustavo Dix
    Negreiros, Izabella Santos
    Santiago Goncalves, Maria Fernanda
    de Paula, Flavia Escremim
    Berardinelli, Gustavo Noriz
    Stanfoca Casagrande, Giovanna Maria
    da Silva, Marcela Oliveira
    Albino da Silva, Eduardo Caetano
    de Oliveira, Marco Antonio
    Jacinto, Alexandre Arthur
    da Silva, Vinicius Duval
    Reis, Rui Manuel
    De Marchi, Pedro
    Leal, Leticia Ferro
    ONCOLOGIST, 2022, 27 (11): : E899 - E907
  • [34] Tumor PD-L1 heterogeneity in non-small cell lung cancer: Does biopsy size and volume matter?
    Khunger, Monica
    Bordeaux, Jennifer
    Dakappagari, Naveen
    Vaupel, Christine
    Khunger, Arjun
    Hu, Bo
    Schalper, Kurt A.
    Rimm, David L.
    Velcheti, Vamsidhar
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Characterizing the Shifting Real-World Treatment Landscape by PD-L1 Testing Status and Expression Level in Advanced Non-Small Cell Lung Cancer
    Ge, Wenzhen
    Wu, Ning
    Quek, Ruben G. W.
    Liu, Jinjie
    Pouliot, Jean-Francois
    Dietz, Hilary
    Jalbert, Jessica J.
    Harnett, James
    Antonia, Scott J.
    ADVANCES IN THERAPY, 2022, 39 (10) : 4645 - 4662
  • [36] Characterizing the Shifting Real-World Treatment Landscape by PD-L1 Testing Status and Expression Level in Advanced Non-Small Cell Lung Cancer
    Wenzhen Ge
    Ning Wu
    Ruben G. W. Quek
    Jinjie Liu
    Jean-Francois Pouliot
    Hilary Dietz
    Jessica J. Jalbert
    James Harnett
    Scott J. Antonia
    Advances in Therapy, 2022, 39 : 4645 - 4662
  • [37] Correlation between PD-L1 expression and clinicopathological characteristics of non-small cell lung cancer: A real-world study of a large Chinese cohort
    Jin, Yan
    Shen, Xuxia
    Pan, Yunjian
    Zheng, Qiang
    Chen, Haiquan
    Hu, Hong
    Li, Yuan
    JOURNAL OF THORACIC DISEASE, 2019, 11 (11) : 4591 - 4601
  • [38] Feasibility and reliability of evaluate PD-L1 expression determination using small biopsy specimens in non-small cell lung cancer
    Chen, Minjiang
    Xu, Yan
    Zhao, Jing
    Li, Ji
    Liu, Xiangning
    Zhong, Wei
    Wang, Mengzhao
    THORACIC CANCER, 2021, 12 (17) : 2339 - 2344
  • [39] Real-World Outcomes for Advanced Non-Small Cell Lung Cancer Patients Treated With a PD-L1 Inhibitor Beyond Progression
    Stinchcombe, Thomas E.
    Miksad, Rebecca A.
    Gossai, Anala
    Griffith, Sandra D.
    Torres, Aracelis Z.
    CLINICAL LUNG CANCER, 2020, 21 (05) : 389 - +
  • [40] Concordance of PD-L1 Expression Between Core Biopsy and Resection Specimens of Non-Small Cell Lung Cancer
    Gradecki, Sarah E.
    Grange, Jacob S.
    Stelow, Edward B.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2018, 42 (08) : 1090 - 1094
12345